IMP
Process View
negative regulation of erythrocyte differentiation
Any process that stops, prevents, or reduces the frequency, rate or extent of erythrocyte differentiation.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of erythrocyte differentiation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| BACH1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | 0.976 | ||
| HOXB5 | homeobox B5 | 0.975 | Human | |
| HOXA5 | homeobox A5 | 0.971 | ||
| HOXA10 | homeobox A10 | 0.971 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.875 | ||
| HOXB7 | homeobox B7 | 0.839 | Human | |
| NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 | 0.791 | ||
| HOXB3 | homeobox B3 | 0.743 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.721 | ||
| HOXB9 | homeobox B9 | 0.638 | ||
| HOXA7 | homeobox A7 | 0.623 | Human | |
| LMO4 | LIM domain only 4 | 0.550 | ||
| HOXA4 | homeobox A4 | 0.531 | Human | |
| HOXB6 | homeobox B6 | 0.511 | Human | |
| WHSC1L1 | Wolf-Hirschhorn syndrome candidate 1-like 1 | 0.481 | ||
| HOXA11 | homeobox A11 | 0.476 | ||
| INSR | insulin receptor | 0.440 | ||
| STAP2 | signal transducing adaptor family member 2 | 0.372 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.354 | ||
| MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) | 0.352 | Human | |
| MAFB | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | 0.341 | ||
| HOXC10 | homeobox C10 | 0.341 | ||
| HOXA6 | homeobox A6 | 0.317 | Human | |
| HOXC6 | homeobox C6 | 0.275 | Human | |
| IL2RB | interleukin 2 receptor, beta | 0.271 | ||
| HOXA2 | homeobox A2 | 0.254 | ||
| INCENP | inner centromere protein antigens 135/155kDa | 0.212 | ||
| RLIM | ring finger protein, LIM domain interacting | 0.208 | ||
| ATF3 | activating transcription factor 3 | 0.194 | ||
| NFIL3 | nuclear factor, interleukin 3 regulated | 0.165 | ||
| HOXA1 | homeobox A1 | 0.148 | ||
| MAPRE2 | microtubule-associated protein, RP/EB family, member 2 | 0.144 | ||
| HOXB4 | homeobox B4 | 0.134 | Human | |
| AGAP2 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 | 0.127 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.127 | ||
| HOXA3 | homeobox A3 | 0.123 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.120 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.107 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.096 | ||
| GATA2 | GATA binding protein 2 | 0.092 | ||
| PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.088 | ||
| MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) | 0.087 | Human | |
| HOXC8 | homeobox C8 | 0.085 | Human | |
| KRT15 | keratin 15 | 0.070 | ||
| HOXC4 | homeobox C4 | 0.069 | Human | |
| CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 0.069 | ||
| HOXC9 | homeobox C9 | 0.068 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.061 | ||
| JAK2 | Janus kinase 2 | 0.055 | ||
| HOXB2 | homeobox B2 | 0.054 | ||
| DUSP5 | dual specificity phosphatase 5 | 0.050 | ||
| NFE2L1 | nuclear factor (erythroid-derived 2)-like 1 | 0.047 | ||
| MAPRE3 | microtubule-associated protein, RP/EB family, member 3 | 0.040 | ||
| HOXD10 | homeobox D10 | 0.037 | ||
| HOXC5 | homeobox C5 | 0.035 | Human | |
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.034 | ||
| FOXO1 | forkhead box O1 | 0.033 | ||
| KEAP1 | kelch-like ECH-associated protein 1 | 0.032 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.031 | ||
| IER2 | immediate early response 2 | 0.030 | ||
| AURKB | aurora kinase B | 0.028 | ||
| HOXA13 | homeobox A13 | 0.027 | ||
| JUND | jun D proto-oncogene | 0.027 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.026 | Human | |
| FMNL1 | formin-like 1 | 0.026 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.026 | ||
| LYL1 | lymphoblastic leukemia derived sequence 1 | 0.025 | ||
| PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.025 | ||
| HOXD8 | homeobox D8 | 0.025 | Human | |
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.023 | ||
| UPP1 | uridine phosphorylase 1 | 0.023 | ||
| GHR | growth hormone receptor | 0.023 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.023 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.022 | ||
| JUN | jun proto-oncogene | 0.022 | ||
| AHR | aryl hydrocarbon receptor | 0.021 | ||
| EPOR | erythropoietin receptor | 0.020 | ||
| IL8 | interleukin 8 | 0.020 | ||
| HOXD4 | homeobox D4 | 0.020 | Human | |
| VEGFA | vascular endothelial growth factor A | 0.020 | ||
| PHLDA2 | pleckstrin homology-like domain, family A, member 2 | 0.020 | ||
| SAT1 | spermidine/spermine N1-acetyltransferase 1 | 0.019 | ||
| GFI1 | growth factor independent 1 transcription repressor | 0.019 | ||
| DAZAP2 | DAZ associated protein 2 | 0.019 | ||
| SH2B1 | SH2B adaptor protein 1 | 0.019 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.019 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.019 | ||
| HOXB8 | homeobox B8 | 0.019 | Human | |
| CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.019 | ||
| GATA4 | GATA binding protein 4 | 0.019 | ||
| SEPT1 | septin 1 | 0.018 | ||
| POU2F1 | POU class 2 homeobox 1 | 0.018 | ||
| PIM1 | pim-1 oncogene | 0.018 | ||
| HOXC11 | homeobox C11 | 0.017 | ||
| CKAP2L | cytoskeleton associated protein 2-like | 0.017 | ||
| OTP | orthopedia homeobox | 0.017 | ||
| HTT | huntingtin | 0.017 | ||
| FOXL1 | forkhead box L1 | 0.017 | ||
| TIPARP | TCDD-inducible poly(ADP-ribose) polymerase | 0.017 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.017 | ||
| MAFIP | MAFF interacting protein | 0.017 | ||
| ARAP1 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 | 0.017 | ||
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.017 | ||
| ITPRIP | inositol 1,4,5-trisphosphate receptor interacting protein | 0.016 | ||
| IER5 | immediate early response 5 | 0.016 | ||
| CCND2 | cyclin D2 | 0.016 | ||
| NDEL1 | nudE nuclear distribution gene E homolog (A. nidulans)-like 1 | 0.015 | ||
| NFIX | nuclear factor I/X (CCAAT-binding transcription factor) | 0.015 | ||
| PITX2 | paired-like homeodomain 2 | 0.015 | ||
| PNRC2 | proline-rich nuclear receptor coactivator 2 | 0.015 | ||
| BTG1 | B-cell translocation gene 1, anti-proliferative | 0.014 | ||
| TCF21 | transcription factor 21 | 0.014 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.014 | ||
| PRDM8 | PR domain containing 8 | 0.014 | ||
| HOXB13 | homeobox B13 | 0.014 | ||
| JUNB | jun B proto-oncogene | 0.014 | ||
| HOXD12 | homeobox D12 | 0.014 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.014 | ||
| PVRL3 | poliovirus receptor-related 3 | 0.014 | ||
| IFRD1 | interferon-related developmental regulator 1 | 0.014 | ||
| PDX1 | pancreatic and duodenal homeobox 1 | 0.014 | ||
| ILVBL | ilvB (bacterial acetolactate synthase)-like | 0.014 | ||
| IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.013 | ||
| CD55 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | 0.013 | ||
| HOXD9 | homeobox D9 | 0.013 | ||
| RGS2 | regulator of G-protein signaling 2, 24kDa | 0.013 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.013 | ||
| HOXD11 | homeobox D11 | 0.013 | ||
| PRTFDC1 | phosphoribosyl transferase domain containing 1 | 0.013 | ||
| KLF6 | Kruppel-like factor 6 | 0.013 | ||
| TWIST1 | twist homolog 1 (Drosophila) | 0.013 | ||
| GATA6 | GATA binding protein 6 | 0.013 | ||
| BCR | breakpoint cluster region | 0.013 | ||
| MSX1 | msh homeobox 1 | 0.013 | ||
| SIK1 | salt-inducible kinase 1 | 0.012 | ||
| RUNX1 | runt-related transcription factor 1 | 0.012 | ||
| DLX2 | distal-less homeobox 2 | 0.011 | ||
| RAC3 | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | 0.011 | ||
| EGR2 | early growth response 2 | 0.011 | ||
| PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | 0.011 | ||
| MEIS1 | Meis homeobox 1 | 0.011 | ||
| MTA2 | metastasis associated 1 family, member 2 | 0.011 | ||
| ANGPT2 | angiopoietin 2 | 0.011 | ||
| TNFRSF21 | tumor necrosis factor receptor superfamily, member 21 | 0.011 | ||
| CTSB | cathepsin B | 0.011 | ||
| HHEX | hematopoietically expressed homeobox | 0.011 | ||
| SSBP2 | single-stranded DNA binding protein 2 | 0.011 | ||
| ARID5A | AT rich interactive domain 5A (MRF1-like) | 0.011 | ||
| FOSL2 | FOS-like antigen 2 | 0.011 | ||
| LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.011 | ||
| EPHB6 | EPH receptor B6 | 0.011 | ||
| EGR3 | early growth response 3 | 0.011 | ||
| SSBP4 | single stranded DNA binding protein 4 | 0.010 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.010 | ||
| CITED1 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 | 0.010 | ||
| EGFR | epidermal growth factor receptor | 0.010 | ||
| JAK3 | Janus kinase 3 | 0.010 | ||
| TXNDC11 | thioredoxin domain containing 11 | 0.010 | ||
| IRAK3 | interleukin-1 receptor-associated kinase 3 | 0.010 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.010 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.010 | ||
| NFATC2 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 | 0.010 | ||
| EPHB3 | EPH receptor B3 | 0.010 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.010 |